Search Results

Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial.

• Authors : Sheng Zhang¹; Ying Zhou¹; Ruiting Zhang¹

Subjects: *FINGOLIMOD; *ALTEPLASE; *STROKE

• Source: International Journal of Stroke. Oct2017, Vol. 12 Issue 8, p906-909. 4p.

Record details

Alteplase in acute ischaemic stroke: no time to slow down.

• Authors : Kiechl, Stefan¹ ; Willeit, Johann¹

Subjects: *STROKE treatment; *ALTEPLASE; *THROMBOLYTIC therapy

• Source: Lancet Neurology. Aug2016, Vol. 15 Issue 9, p893-895. 3p.

Record details

In imaging-selected ischemic stroke with unknown onset, alteplase increases favorable outcomes and death at 90 d.

• Authors : Hill, Michael D.¹ (AUTHOR)

Subjects: *ISCHEMIC stroke; *ALTEPLASE; *BIBLIOGRAPHICAL citations

• Source: Annals of Internal Medicine. 4/20/2021, Vol. 174 Issue 4, pJC42-JC42. 1p. 1 Chart.

Record details

Alteplase.

Subjects: *CEREBRAL ischemia; *ALTEPLASE; *DRUG side effects

• Source: Reactions Weekly. Aug2015, Vol. 1564 Issue 1, p20-20. 1p.

Record details

Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm.

• Authors : Chen, Xiaoying; Li, Jingwei; Anderson, Craig S

Subjects: CLINICAL trial registries; STROKE; ATRIAL fibrillationNATIONAL Institutes of Health (U.S.)

• Source: International Journal of Stroke; Feb2021, Vol. 16 Issue 2, p222-228, 7p

Record details

Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.

• Authors : Whiteley, William N¹; Emberson, Jonathan²; Lees, Kennedy R³

Subjects: *HEMORRHAGE risk factors; *ALTEPLASE; *STROKE treatment

• Source: Lancet Neurology. Aug2016, Vol. 15 Issue 9, p925-933. 9p.

Record details

Intravenous Alteplase for Mild Nondisabling Acute Ischemic Stroke: A Bridge Too Far?

• Authors : Powers, William J.

Subjects: FIBRINOLYTIC agents; CEREBRAL ischemia; STROKE

• Source: JAMA: Journal of the American Medical Association; 7/10/2018, Vol. 320 Issue 2, p141-143, 3p

Record details

Hesperidin reduces adverse symptomatic intracerebral hemorrhage by promoting TGF-β1 for treating ischemic stroke using tissue plasminogen activator.

• Authors : Qin, Zhanzhong (AUTHOR); Chen, Linlin (AUTHOR); Liu, Min (AUTHOR)

Subjects: NATIONAL Institutes of Health (U.S.); TISSUE plasminogen activator; NIH Stroke Scale

• Source: Neurological Sciences. Jan2020, Vol. 41 Issue 1, p139-147. 9p. 1 Diagram, 3 Charts, 4 Graphs.

Record details

Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.

• Authors : Chen, Xiaoying; Delcourt, Candice; Sun, Lingli

Subjects: QUALITY of life; BRAIN imaging; CEREBRAL ischemiaNATIONAL Institutes of Health (U.S.)

• Source: Cerebrovascular Diseases; 2020, Vol. 49 Issue 4, p427-436, 10p

Record details

Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.

• Authors : Khatri, Pooja; Kleindorfer, Dawn O.; Devlin, Thomas

Subjects: THERAPEUTIC use of fibrinolytic agents; FIBRINOLYTIC agents; ASPIRIN

• Source: JAMA: Journal of the American Medical Association; 7/10/2018, Vol. 320 Issue 2, p156-166, 11p

Record details